SE9201966D0 - Interleukin-1beta deletion mutant - Google Patents

Interleukin-1beta deletion mutant

Info

Publication number
SE9201966D0
SE9201966D0 SE9201966A SE9201966A SE9201966D0 SE 9201966 D0 SE9201966 D0 SE 9201966D0 SE 9201966 A SE9201966 A SE 9201966A SE 9201966 A SE9201966 A SE 9201966A SE 9201966 D0 SE9201966 D0 SE 9201966D0
Authority
SE
Sweden
Prior art keywords
interleukin
beta
deletion
deletion mutant
receptors
Prior art date
Application number
SE9201966A
Other languages
English (en)
Inventor
T Bartfai
Original Assignee
Trion Forskning & Utveckling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trion Forskning & Utveckling filed Critical Trion Forskning & Utveckling
Priority to SE9201966A priority Critical patent/SE9201966D0/sv
Publication of SE9201966D0 publication Critical patent/SE9201966D0/sv
Priority to EP93915072A priority patent/EP0647238A1/en
Priority to JP6502266A priority patent/JPH07508408A/ja
Priority to AU45191/93A priority patent/AU4519193A/en
Priority to PCT/SE1993/000562 priority patent/WO1994000491A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
SE9201966A 1992-06-25 1992-06-25 Interleukin-1beta deletion mutant SE9201966D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9201966A SE9201966D0 (sv) 1992-06-25 1992-06-25 Interleukin-1beta deletion mutant
EP93915072A EP0647238A1 (en) 1992-06-25 1993-06-23 INTERLEUKIN-1$g(b) DELETION MUTANT
JP6502266A JPH07508408A (ja) 1992-06-25 1993-06-23 インターロイキン‐１β欠失変異体
AU45191/93A AU4519193A (en) 1992-06-25 1993-06-23 Interleukin-1beta deletion mutant
PCT/SE1993/000562 WO1994000491A1 (en) 1992-06-25 1993-06-23 INTERLEUKIN-1β DELETION MUTANT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9201966A SE9201966D0 (sv) 1992-06-25 1992-06-25 Interleukin-1beta deletion mutant

Publications (1)

Publication Number Publication Date
SE9201966D0 true SE9201966D0 (sv) 1992-06-25

Family

ID=20386611

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9201966A SE9201966D0 (sv) 1992-06-25 1992-06-25 Interleukin-1beta deletion mutant

Country Status (5)

Country Link
EP (1) EP0647238A1 (sv)
JP (1) JPH07508408A (sv)
AU (1) AU4519193A (sv)
SE (1) SE9201966D0 (sv)
WO (1) WO1994000491A1 (sv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114163514A (zh) * 2021-12-13 2022-03-11 青岛瑞斯凯尔生物科技有限公司 Il-10突变体及其应用

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4408890A1 (de) * 1994-03-16 1995-09-21 Knoll Ag Verwendung von Il-1-Antagonisten als Arzneimittel zur Behandlung von Erkrankungen mit einem erhöhten Interleukin-6 Serumspiegel
US5986059A (en) 1996-06-14 1999-11-16 Bayer Corporation T-cell selective interleukin-4 agonists
US6335426B1 (en) 1996-06-14 2002-01-01 Bayer Corporation T-cell selective interleukin-4 agonists
US6028176A (en) 1996-07-19 2000-02-22 Bayer Corporation High-affinity interleukin-4 muteins
US5978749A (en) * 1997-06-30 1999-11-02 Pile Dynamics, Inc. Pile installation recording system
US6270758B1 (en) 1998-10-08 2001-08-07 Duke University Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects
CA3003969A1 (en) 2015-11-06 2017-05-11 Orionis Biosciences Nv Bi-functional chimeric proteins and uses thereof
JP6991979B2 (ja) 2016-02-05 2022-03-04 オリオニス バイオサイエンシズ ビーブイ Ｃｄ８結合物質
US11248057B2 (en) 2016-03-07 2022-02-15 Vib Vzw CD20 binding single domain antibodies
EP3454887B1 (en) 2016-05-13 2021-01-20 Orionis Biosciences BV Targeted mutant interferon-beta and uses thereof
CN109563141A (zh) 2016-05-13 2019-04-02 奥里尼斯生物科学公司 对非细胞结构的治疗性靶向
CA3040802A1 (en) 2016-10-24 2018-05-03 Orionis Biosciences Nv Targeted mutant interferon-gamma and uses thereof
WO2018144999A1 (en) 2017-02-06 2018-08-09 Orionis Biosciences, Inc. Targeted engineered interferon and uses thereof
MX2019009255A (es) 2017-02-06 2019-11-05 Orionis Biosciences Nv Proteínas quiméricas dirigidas y sus usos.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2591615B2 (ja) * 1986-03-14 1997-03-19 大塚製薬株式会社 インターロイキン−１β誘導体及び医薬
FR2667601A1 (fr) * 1990-10-05 1992-04-10 Rhone Poulenc Sante Polypeptides derives de l'interleukine-1 beta, procede de preparation et utilisation, notamment dans le cadre des pathologies osteoarticulaires.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114163514A (zh) * 2021-12-13 2022-03-11 青岛瑞斯凯尔生物科技有限公司 Il-10突变体及其应用
CN114163514B (zh) * 2021-12-13 2023-05-26 青岛瑞斯凯尔生物科技有限公司 Il-10突变体及其应用

Also Published As

Publication number Publication date
AU4519193A (en) 1994-01-24
JPH07508408A (ja) 1995-09-21
WO1994000491A1 (en) 1994-01-06
EP0647238A1 (en) 1995-04-12

Similar Documents

Publication Publication Date Title
SE9201966D0 (sv) Interleukin-1beta deletion mutant
Hirano et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin
Oppenheim et al. There is more than one interleukin 1
GOSPODAROWICZ et al. Stimulation of division of Yl adrenal cells by a growth factor isolated from bovine pituitary glands
ZA943464B (en) Vascular endothelial growth factor 2
DE68918867T2 (de) Mutanten des hiv-1 Hüllproteins mit fehlenden hypervariabelen domänen.
ATE221125T1 (de) Klonierte glutaminsäure-decarboxylase
MY101887A (en) A novel human physiologically active polypeptide.
ATE194651T1 (de) Stammzellenfaktor
DE69939330D1 (de) Wachstumsfaktor-homologe zvegf-3
BG60238B1 (bg) Човешки тумор- некротизиращ фактор
DE69229862T2 (de) Cysteinfreie il-6 mutanten
ATE154638T1 (de) Mutanten von interleukin-3
Morhenn The etiology of lichen planus: a hypothesis
Ulloa-Aguirre et al. Effects of gonadotrophin-releasing hormone, recombinant human activin-A and sex steroid hormones upon the follicle-stimulating isohormones secreted by rat anterior pituitary cells in culture
FI945877A (sv) Förfarande för att producera protein C
FI915654A (fi) Somatotropiner med alterneringar i alfahelixregionen 1 och kombinationer med andra mutationer.
ES8605296A1 (es) Procedimiento de producir factor viii-r humano
EP0244677A3 (en) Method of producing peptides, recombinant plasmid for use in the same and animal cells transformed with the same
DK0667872T3 (da) Mutantinterleukin 6 med forbedret biologisk aktivitet i forhold til vildtype-interleukin 6
MXPA01011158A (es) Factor de crecimiento homologo zvegf4.
AU637589B2 (en) Ancrod proteins, their production and use
Mizel Interleukin-1: biology and molecular biology
Dukovich The Purification and Biochemical Characterization of Natural and Recombinant Interleukin 1
ES2120958T3 (es) Nuevas proteinas con actividad de oncostatina m y procedimiento para su preparacion.